Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS)

CUSIP: H5870P102

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Ordinary Shares, par value CHF 0.01 per share
Shares outstanding
58,900,797
Total 13F shares
18,020,789
Share change
+4,525,547
Total reported value
$361,237,998
Price per share
$19.97
Number of holders
40
Value change
+$90,374,744
Number of buys
27
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP H5870P102?
CUSIP H5870P102 identifies OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
EQT Fund Management S.a r.l.
13F
Company
10%
5,900,294
$103,727,169 30 Sep 2025
13F
Pivotal bioVenture Partners Fund I, L.P.
13D/G
Nan Fung Group Holdings Limited
4.9%
2,815,476
$49,946,544 $0 30 Sep 2025
Pivotal bioVenture Partners Investment Advisor LLC
13F
Company
3.9%
2,300,774
$40,447,607 30 Sep 2025
13F
Aberdeen Group plc
13F
Company
2.1%
1,253,119
$22,217,800 30 Sep 2025
13F
Nan Fung Group Holdings Ltd
13F
Company
0.87%
514,702
$9,048,461 30 Sep 2025
13F
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
0.55%
322,500
$5,669,550 30 Sep 2025
13F
Alyeska Investment Group, L.P.
13F
Company
0.22%
131,332
$2,308,817 30 Sep 2025
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.17%
101,777
$1,789,240 30 Sep 2025
13F
Lombard Odier SCmA Compagnie
13F
Individual
0.16%
97,000
$1,719,810 30 Sep 2025
13F
Woodline Partners LP
13F
Company
0.14%
83,833
$1,473,784 30 Sep 2025
13F
UBS Group AG
13F
Company
mixed-class rows
74,902
mixed-class rows
$1,314,938 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.07%
38,535
$677,446 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.05%
29,436
$521,900 30 Sep 2025
13F
MMCAP International Inc. SPC
13F
Company
class O/S missing
73,525
$497,029 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.04%
21,804
$383,314 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
class O/S missing
45,701
$308,939 30 Sep 2025
13F
MOORE CAPITAL MANAGEMENT, LP
13F
Company
class O/S missing
41,666
$281,662 30 Sep 2025
13F
STATE STREET CORP
13F
Company
0.02%
12,379
$219,480 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
35,616
$213,696 30 Sep 2025
13F
GABELLI & Co INVESTMENT ADVISERS, INC.
13F
Company
class O/S missing
18,601
$125,743 30 Sep 2025
13F
Mint Tower Capital Management B.V.
13F
Company
class O/S missing
18,333
$124,000 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.01%
6,416
$112,793 30 Sep 2025
13F
GABELLI FUNDS LLC
13F
Company
class O/S missing
13,670
$92,409 30 Sep 2025
13F
Aventura Private Wealth, LLC
13F
Company
0.01%
4,000
$70,320 30 Sep 2025
13F
Vestcor Inc
13F
Company
class O/S missing
11,666
$70,000 30 Sep 2025
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
mixed-class rows
3,317
mixed-class rows
$25,333 30 Sep 2025
13F
China Universal Asset Management Co., Ltd.
13F
Company
0%
1,000
$17,580 30 Sep 2025
13F
DUPONT CAPITAL MANAGEMENT CORP
13F
Company
0%
4
$71 30 Sep 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
1
$18 30 Sep 2025
13F

Institutional Holders of Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS) as of Q4 2025

As of 31 Dec 2025, Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,020,789 shares. The largest 10 holders included EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, Aberdeen Group plc, WELLINGTON MANAGEMENT GROUP LLP, SR One Capital Management, LP, Saturn V Capital Management LP, Nan Fung Group Holdings Ltd, PERCEPTIVE ADVISORS LLC, and Alyeska Investment Group, L.P.. This page lists 40 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
20
Q4 2025 holders
40
Holder diff
20
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .